Bisphosphonates, hypercalcemia of malignancy, and osteonecrosis of the jaw.
Wynn
Richard L
RL
Department of Oral Craniofacial Biological Sciences, Dental School, University of Maryland, Baltimore, USA.
D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy* / Q000209:etiology; D007571:Jaw Diseases / Q000139:chemically induced* / Q000517:prevention & control; D009369:Neoplasms / Q000150:complications*; D010020:Osteonecrosis / Q000139:chemically induced* / Q000517:prevention & control
D050071:Bone Density Conservation Agents; D004164:Diphosphonates